10174 results about "After treatment" patented technology

A system and method of obtaining serial biochemical, anatomical or physiological in vivo measurements of disease from one or more medical images of a patient before, during and after treatment, and measuring extent and severity of the disease is provided. First anatomical and functional image data sets are acquired, and form a first co-registered composite image data set. At least a volume of interest (ROI) within the first co-registered composite image data set is identified. The first co-registered composite image data set including the ROI is qualitatively and quantitatively analyzed to determine extent and severity of the disease. Second anatomical and functional image data sets are acquired, and form a second co-registered composite image data set. A global, rigid registration is performed on the first and second anatomical image data sets, such that the first and second functional image data sets are also globally registered. At least a ROI within the globally registered image data set using the identified ROI within the first co-registered composite image data set is identified. A local, non-rigid registration is performed on the ROI within the first co-registered composite image data set and the ROI within the globally registered image data set, thereby producing a first co-registered serial image data set. The first co-registered serial image data set including the ROIs is qualitatively and quantitatively analyzed to determine severity of the disease and/or response to treatment of the patient.

Method for assessing the patency of a patient's blood vessel, advantageously during or after treatment of that vessel by an invasive procedure, comprising administering a fluorescent dye to the patient; obtaining at least one angiographic image of the vessel portion; and evaluating the at least one angiographic image to assess the patency of the vessel portion. Other related methods are contemplated, including methods for assessing perfusion in selected body tissue, methods for evaluating the potential of vessels for use in creation of AV fistulas, methods for determining the diameter of a vessel, and methods for locating a vessel located below the surface of a tissue.

Well treatment is disclosed that includes injecting a well treatment fluid with insoluble polyol polymer such as polyvinyl alcohol (PVOH) dispersed therein, depositing the insoluble polymer in the wellbore or an adjacent formation, and thereafter dissolving the polymer by reducing salinity and/or increasing temperature conditions in the environment of the polymer deposit. The method is disclosed for filter cake formation, fluid loss control, drilling, hydraulic fracturing and fiber assisted transport, where removal of the polyol at the end of treatment or after treatment is desired. The method is also disclosed for providing dissolved polyol as a delayed breaker in crosslinked polymer viscosified systems and viscoelastic surfactant systems. Also disclosed are well treatment fluids containing insoluble amorphous or at least partially crystalline polyol, and a PVOH fiber composition wherein the fibers are stabilized from dissolution by salinity.

A compression garment for selective application for treatment of lymphedema and prevention of local ischemia of tissues at various locations of the body. The garment includes a pair or series of layers of hermetically sealed material, that can capture pressurized air, when applied therein, and is formed through the patterned sealing of the layers of the garment together, at select locations, to form air pockets that can selectively apply isolated points of pressure to the patient's affected area, without disrupting normal vascular and lymphatic functioning. The garment is design cut, for application to various segments of the body, and applies encompassing pressure over the entire affected area, and includes valves that can allow for the injection of measurable air, to the desired pressure points, or its deflation, after treatment. The compression device of this invention may also be formed as a segmented pad or mat, into which pneumatic pressurized air may be applied, at various segments, so as to regulate the amount of pressure applied to the surface of the body that is in contact with the pad or mat of this invention.

Nicotine dependency is treated by administration of an opioid antagonist. In some embodiments, rapid or ultra rapid detoxification techniques include using a combination of an effective amount of an opioid antagonist such as nalmefene, naloxone or naltrexone or a mixture of any one of these, and either clonidine or related compounds either while awake, or while under sedation or anesthesia, followed by continued administration of an effective amount of an opioid antagonist with or without agents that enhance nicotine dependency treatment. Persons are also treated for nicotine dependency with more gradual detoxification methods using administration of a combination of an effective amount of an opioid antagonist such as nalmefene, naloxone, naltrexone, or a mixture of any of these, and an effective amount of agents used to treat nicotine withdrawal including nicotine, such as that delivered by a nicotine patch, nicotine chewing gum, nicotine inhaler or other methods for delivering nicotine, antidepressants and antianxiety agents, and/or clonidine and related compounds. Administration of an effective amount of an opioid antagonist to prevent relapse, attenuate craving, and reduce weight gain during and after treatment for nicotine dependency is continued in some embodiments.

A gastrointestinal implant device is positioned in a patient's small intestine or rectum and produces an outward force that itself produces a distension signal which is a therapeutically useful neural or humoral signal that evokes satiogenic or weight loss effects by itself. The device may advantageously be placed in the duodenum adjacent the pylorus or in the jejunum, ileum or rectum. The distension signals may amplify chemosensory or mechanosensory signals such as enteroendocrine secretions within the patient. The device may be a mesh and include a low material density that allows for unrestricted chyme absorption within the small intestine and unrestricted chyme flow through the gastrointestinal system. A method includes inserting the device into the patient then either retrieving the device after treatment is complete or allowing a device formed of a biodegradable material to degrade in time after treatment is complete.

Biological samples including cell-free DNA fragments are analyzed to identify imbalances in chromosomal regions, e.g., due to deletions and/or amplifications in a tumor. Multiple loci are used for each chromosomal region. Such imbalances can then be used to diagnose (screen) a patient for cancer, as well as prognosticate a patient with cancer, or to detect the presence or to monitor the progress of a premalignant condition in a patient. The severity of an imbalance as well as the number of regions exhibiting an imbalance can be used. A systematic analysis of non-overlapping segments of a genome can provide a general screening tool for a sample. Additionally, a patient can be tested over time to track severity of each of one or more chromosomal regions and a number of chromosomal regions to enable screening and prognosticating, as well as monitoring of progress (e.g. after treatment).

A reductant delivery unit (10) is provided for selective catalytic reduction (SCR) after-treatment for vehicles. The unit includes a solenoid fluid injector (10) constructed and arranged to be associated with an exhaust gas flow path (14) upstream of a SCR catalytic converter (17). The fluid injector has a fluid inlet (13) and a fluid outlet (15) with the fluid inlet being constructed and arranged to receive a source of urea solution and the fluid outlet being constructed and arranged to communicate directly with the exhaust flow path so as to control injection of urea solution into the exhaust gas flow path. An interface (24) is constructed and arranged to couple the fluid injector to the gas flow path. The interface defines a thermal barrier constructed and arranged to decoupled a body of the injector from exposure to heat in the exhaust gas flow path.

The present invention provides methods for improving the performance of a consumer wrinkle control composition by making the composition available to the consumer and providing information to the consumer concerning the use of the composition to control wrinkles in fabrics without the application of heat. Information may be provided by teaching educational elements and disseminating educational elements to consumers in an efficient, effective, and affordable manner as well as techniques for heightening consumer awareness of the product. The information that is provided to the consumer may concerns the use of the composition to remove or control wrinkles in fabrics without the application of heat, instructions for the proper use of the product, the product's effectiveness, the appearance of the fabric in the finished state after treatment, how the product can be incorporated into the consumer's everyday habits and lifestyles, additional non-wrinkle related benefits that may be achieved with the product and how the composition can be effectively and safely used by most members of the consumer's household. Also provided are methods for prolonging or extending the useful life of fabric items that require frequent and repeated laundering processes and that are prone to cause incremental damage to fabric fibers. The useful life of such fabric items is prolonged by enabling the item to be revitalized or renewed for rewear without laundering, thus reducing the number of launderings and the resulting damage to fabric fibers over a given period of time.

In one embodiment, a system may include a gas turbine system. the gas turbine system includes a gas turbine, an after-treatment system that may receive exhaust gases from the gas turbine system, and a controller that may receive inputs and model operational behavior of an industrial plant based on the inputs. The industrial plant may include the gas turbine and the after-treatment system. The controller may also determine one or more operational parameter setpoints for the industrial plant, select the one or more operational parameter setpoints that reduce an output of a cost function, and apply the one or more operational parameter setpoints to control the industrial plant.

The invention relates generally to systems and devices for material delivery, energy delivery, and/or monitoring electrophysiological activity, and method of use thereof. In particular, the present invention provides devices and systems, and methods of use thereof, configured to deliver therapeutic compositions, to provide electroporation and/or sonoporation to increase therapeutic efficiency, and to monitor electrophysiological activity, for example, before and after treatment.

Computer-implemented methods to plan, display and evaluate orthodontic treatment plans. A plurality of teeth in a representation on a computer display may be moved simultaneously in accordance with a mathematically defined pattern. Software tools available to generate the treatment path may include adjusting the smile teeth, moving teeth along a curve fit to points in the mandible, individually moving a tooth, cross sectioning to check for interference and simulations of occlusal points, highlighting teeth that have moved from their original position, making notations on the teeth, and generating and saving animation sequences of before and after treatment tooth positions.

A modified starch material for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.

The present invention provides a method for exchanging catheters while containing emboli within a blood vessel such as a saphenous vein graft, coronary artery, carotid artery, or other similar vessels. A guidewire is inserted through the vasculature of a patient until it reaches a desired treatment site. A therapy catheter is then inserted over the guidewire until the distal end of the therapy catheter reaches the treatment site. The guidewire has a distally mounted balloon which is inflated to occlude the blood vessel. Then, the therapy catheter provides means for treating the vessel at the treatment site. After treatment, the therapy catheter is removed from the guidewire and exchanged with an aspiration catheter which rides over the guidewire until the distal end of the aspiration catheter reaches the treatment site. The aspiration catheter applies negative pressure to remove any emboli formed by the treatment procedure.

An apparatus and method for treating and reusing the wastewater discharged from agricultural animal farms. The apparatus and method of the present invention is designed to be a zero discharge system in which no wastewater will be discharged or spray irrigated. The wastewater effluent is first passed through a mechanical screen were bulk solids are separated and partially de-watered. The screened effluent is then directed to a primary plastic-lined earthen lagoon where it undergoes aerobic digestion utilizing specially selected bacteria. After treatment in the primary lagoon, the wastewater effluent is used to wash the floors of the hog houses or undergoes a purification phase including solids separation/denitrification, filtration and sterilization. The solids separation/denitrification phase (clarification) preferably takes place in an anoxic environment in preferably above-ground tanks where suspended solids removal will occur as well as denitrification for nitrate reduction. The clarification process may be facilitated through use of polymer addition. The majority of solids will be sent to a plurality of drying beds for de-watering and subsequent removal.

The present invention provide a lubricating oil composition suitable for internal combustion engines, which composition is excellent in thermal/oxidation stability and can inhibit the increases of the viscosity and acid number even in the presence of NOx and can be used for a long period of time or provide a lubricating oil composition particularly suitable for diesel or direct injection engines equipped with an exhaust-gas after-treatment device such as DPF or various catalysts, which composition is excellent in high-temperature detergency and base number retention properties and further can achieve the effect of inhibit wear caused by soot contamination in the oil occurring significantly when the content of phosphorus compounds such as ZnDTP is decreased, at a high level and can inhibit the exhaust-gas after-treatment device from being adversely affected. The lubricating oil composition comprises a lubricating base oil containing, a specific amount of a base oil with specific properties, and two or more types of additives selected from specific additives.

The invention discloses a preparation method of a catalytic wet oxidation catalyst and a treatment method of organic wastewater. The preparation method comprises the following steps of: (1) taking a porous inert material as a carrier, and performing pre-impregnation treatment on the carrier by adopting an organic acid solution; and (2) preparing an impregnating solution with a water-soluble compound containing transition metal elements and a water-soluble compound containing auxiliary elements, impregnating the carrier after treatment in the step (1) with the impregnating solution, drying in shade for 12-48 hours in air at appropriate humidity, then drying and roasting to obtain a final catalyst. When the catalyst prepared by the method disclosed by the invention is used for high-concentration organic wastewater, the characteristics of high activity, good stability and the like are realized, and the energy consumption and the investment can be reduced.

The invention surprisingly finds that when a suitable binder including a suitable filler is used during the high temperature treatment of a curing process, the coating materials of the invention change in such a manner that electrically conducting reactive layers are formed that allow welding and especially spot welding together with the metal substrate even after treatment at temperatures of more than 800 DEG C.

The present disclosure relates to nanoparticle-containing implantable and preferably biodegradable medical products and their use for the thermotherapeutic after-treatment after surgical removal of tumors and cancerous ulcers.

The invention discloses a method for preparation of a columnar jointed rock mass similar material sample by a 3D printing technology. The method includes: preparing powdered 3D printing raw materials: powder, columnar jointed column powder, joint needed powder and cementing bonding powder; loading the powdered materials into a 3D printer; establishing a columnar jointed sample three-dimensional model, and inputting the model into the 3D printer to conduct 3D printing; and carrying out after-treatment on the sample at the end of printing. The method provided by the invention applies the 3D printing technology into rock mechanical test for the first time, uses a similar material to simulate the basic characteristics of a columnar jointed rock mass in actual engineering, and has the advantages of simple preparation process, higher production efficiency than artificial sample preparation, and high yield, etc.

The present invention provides a lubricating oil composition, which is capable to maintain sufficient low-friction (i.e. fuel saving performance) even when the lubricating oil is contaminated with soot and metal abrasion powder, which is excellent in durability with regard to anti-wear property and detergency, as well as oxidation stability, and which is capable to lower the ash content and to sufficiently maintain the performance of exhaust-gas after-treatment device for a long term. The lubricating oil composition comprises a lubricant base oil containing a base oil (X) of which % C_P is 70 or more, % C_A is 1 or less, viscosity index is 115 or more, and CCS viscosity at −35° C. is 3000 mPa·s or less, wherein the lubricant base oil, to total mass of the composition, contains following components (A)˜(D):

• (A) 0.01˜10 mass % of ashless friction modifier;
• (B) 0.01˜0.2 mass % of phosphorus-containing anti-wear agent as phosphorous content;
• (C) 0.01˜1 mass % of metallic detergent as metal content; and
• (D) 0.01˜0.4 mass % of ashless dispersant having 3000˜20000 of weight-average molecular weight as nitrogen content.